Home > Qtrly Results > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Quarterly Results Analysis [Sep2024]

KILITCH DRUGS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Quarterly Results

Consolidated Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Revenues ₹47 Cr ₹33 Cr ₹45 Cr ₹32 Cr ₹41 Cr ₹37 Cr ₹45 Cr ₹30 Cr
Expenses ₹41 Cr ₹32 Cr ₹38 Cr ₹30 Cr ₹33 Cr ₹30 Cr ₹39 Cr ₹26 Cr
Operating Income ₹6 Cr ₹2 Cr ₹7 Cr ₹2 Cr ₹9 Cr ₹6 Cr ₹6 Cr ₹4 Cr
Other Income ₹5 Cr ₹3 Cr ₹0 Cr ₹3 Cr ₹0 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Interest ₹0 Cr ₹2 Cr ₹1 Cr ₹2 Cr ₹2 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹10 Cr ₹2 Cr ₹5 Cr ₹3 Cr ₹7 Cr ₹4 Cr ₹5 Cr ₹2 Cr
Profit After Tax ₹9 Cr ₹0 Cr ₹4 Cr ₹2 Cr ₹5 Cr ₹3 Cr ₹3 Cr ₹2 Cr
EPS ₹5.36 ₹0.83 ₹2.23 ₹1.81 ₹2.95 ₹2.15 ₹2.29 ₹1.52
Industry Peers & Returns1W1M1Y
KILITCH DRUGS (INDIA) -2% 1.6% -12.6%
SUN PHARMACEUTICAL INDUSTRIES 3.7% 8.5% 49.4%
CIPLA 3% 1.9% 20.9%
DR REDDYS LABORATORIES 2.7% 15.5% 23.2%
ZYDUS LIFESCIENCES -1.6% 1% 43.9%
DIVIS LABORATORIES 3.6% 1.8% 52.1%
MANKIND PHARMA -4.9% 11.4% 49.2%
TORRENT PHARMACEUTICALS -1.4% 5.3% 49.3%
LUPIN 6.9% 15.6% 73.7%

KILITCH DRUGS (INDIA) Quarterly Revenues

Revenues
Q-o-Q

41.92 %

Y-o-Y

15.22 %

Quarters Revenues % Change
Sep2024 ₹47 Cr
41.92
Jun2024 ₹33 Cr
-25.36
Mar2024 ₹45 Cr
40.97
Dec2023 ₹32 Cr
-22.83
Sep2023 ₹41 Cr
12.71
Jun2023 ₹37 Cr
-19.61
Mar2023 ₹45 Cr
51.73
Dec2022 ₹30 Cr -

KILITCH DRUGS (INDIA) Quarterly Operating Profit

Operating Profit
Q-o-Q

267.05 %

Y-o-Y

-29.31 %

Quarters Operating Profit % Change
Sep2024 ₹6 Cr
267.05
Jun2024 ₹2 Cr
-76.55
Mar2024 ₹7 Cr
210.57
Dec2023 ₹2 Cr
-73.56
Sep2023 ₹9 Cr
39.49
Jun2023 ₹6 Cr
-0.55
Mar2023 ₹6 Cr
56.11
Dec2022 ₹4 Cr -
Operating Margins
Q-o-Q

158.67 %

Y-o-Y

-38.67 %

Quarters Operating Margin% % Change
Sep2024 12.83%
158.67
Jun2024 4.96%
-68.59
Mar2024 15.79%
120.22
Dec2023 7.17%
-65.73
Sep2023 20.92%
23.79
Jun2023 16.9%
23.72
Mar2023 13.66%
2.86
Dec2022 13.28% -

KILITCH DRUGS (INDIA) Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

7,589.29 %

Y-o-Y

69.09 %

Quarters Profit After Tax % Change
Sep2024 ₹9 Cr
7,589.29
Jun2024 ₹0 Cr
-96.96
Mar2024 ₹4 Cr
111.37
Dec2023 ₹2 Cr
-65.80
Sep2023 ₹5 Cr
66.38
Jun2023 ₹3 Cr
5.52
Mar2023 ₹3 Cr
69.85
Dec2022 ₹2 Cr -
PAT Margins
Q-o-Q

5,396.97 %

Y-o-Y

46.76 %

Quarters PAT Margin(%) % Change
Sep2024 18.14 %
5,396.97
Jun2024 0.33 %
-95.99
Mar2024 8.22 %
50.00
Dec2023 5.48 %
-55.66
Sep2023 12.36 %
47.67
Jun2023 8.37 %
31.19
Mar2023 6.38 %
11.93
Dec2022 5.7 % -

KILITCH DRUGS (INDIA) Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

545.78 %

Y-o-Y

81.69 %

Quarters EPS % Change
Sep2024 ₹5.36
545.78
Jun2024 ₹0.83
-62.78
Mar2024 ₹2.23
23.20
Dec2023 ₹1.81
-38.64
Sep2023 ₹2.95
37.21
Jun2023 ₹2.15
-6.11
Mar2023 ₹2.29
50.66
Dec2022 ₹1.52 -

You may also like the below Video Courses